Chemoprevention of dietary digitoflavone on colitis-associated colon tumorigenesis through inducing Nrf2 signaling pathway and inhibition of inflammation by Yang Yang et al.
Yang et al. Molecular Cancer 2014, 13:48
http://www.molecular-cancer.com/content/13/1/48RESEARCH Open AccessChemoprevention of dietary digitoflavone on
colitis-associated colon tumorigenesis through
inducing Nrf2 signaling pathway and inhibition of
inflammation
Yang Yang1, Xueting Cai1, Jie Yang1, Xiaoyan Sun1, Chunping Hu1, Zhanpeng Yan1, Xiaojun Xu2, Wuguang Lu1,
Xiaoning Wang1 and Peng Cao1,2*Abstract
Background: Nuclear factor-erythroid 2-related factor 2 (Nrf2) has emerged as a novel target for the prevention of
colorectal cancer (CRC). Many chemopreventive compounds associated with Nrf2 activation are effective in
preclinical systems and many on-going clinical trials are showing promising findings. In present study we evaluated
the cytoprotective effect and chemopreventive properties of dietary digitoflavone.
Method: A cell based Antioxidant Response Element (ARE)-driven luciferase reporter system was applied to screen
potential Nrf2 activators. Activation of Nrf2 by digitoflavone was confirmed through mRNA, protein and GSH level
assay in Caco-2 cell line. The cytoprotective effect of digitoflavone was evaluated in H2O2-induced oxidative stress
model and further signaling pathways analysis was used to determine the target of digitoflavone induced Nrf2
activation. An AOM-DSS induced colorectal cancer model was used to assess the chemopreventive effect of
digitoflavone.
Result: Micromolarity (10 μM) level of digitoflavone increased Nrf2 expressing, nuclear translocation and expression
of downstream phase II antioxidant enzymes. Furthermore, digitoflavone decreased H2O2-induced oxidative stress
and cell death via p38 MAPK-Nrf2/ARE pathway. In vivo study, 50 mg/kg digitoflavone significantly reduced
AOM-DSS induced tumor incidence, number and size.
Conclusion: These observations suggest that digitoflavone is a novel Nrf2 pathway activator, and protects against
oxidative stress-induced cell injury. The results of the present study add further evidence of the molecular mechanisms
that allow digitoflavone to exert protective effects and reaffirm its potential role as a chemopreventive agent in
colorectal carcinogenesis.
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Gastrointestinal tract is body’s digestion and absorption
organ and frequently faces the challenges from xenobi-
otics and endogenous toxic substances-induced oxidative
stress due to its particular location and function. Also,
Reactive Oxygen Species (ROS) are involved in many* Correspondence: pcao79@yahoo.com
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unless otherwise stated.physiological functions and colorectal pathological pro-
cesses, such as Crohn’s disease, ulcerative colitis, and
colorectal cancer (CRC) [1-3]. Therefore, there is an in-
creasing interest in the potential effects of exogenous
antioxidants on the prevention of oxidative gastrointes-
tinal disorders. Recently, Up-regulation of endogenous
antioxidant and phase II antioxidant enzymes by Nrf2
has emerged as a novel target for the prevention of CRC
since it is currently well accepted that chronic inflamma-
tion is a contributing factor in 15-20% malignancies in-
cluding CRC [4] and that this inflammation can bed. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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http://www.molecular-cancer.com/content/13/1/48attributed to a number of factors including oxidative
stress, reactive oxygen species (ROS) and reactive nitrogen
species (RNS).
Phase II metabolizing-detoxifying and antioxidant
defense enzymes [such as NADP(H) quinone oxidoreduc-
tase 1 (NQO-1), heme oxygenase-1 (HO-1), and aldo-keto
reductase1 subunits C-1 ( AKR1C1), C-2 ( AKR1C2) and
C-3 (AKR1C3) ] , antioxidants [such as γ-glutamylcysteine
synthetase catalytic subunit(γ-GCSc) , γ-glutamylcysteine
synthetase modifier subunit (γ-GCSm), glutathione reduc-
tase (GR), thioredoxin reductase (TR) and peroxiredoxin
(Prx)], and ATP-dependent drug efflux pumps [ATP- bind-
ing cassette, subfamily C(CFTR/MRP) members (ABCC2,
ABCC3, ABCC4)] are regulated by cis-acting regulatory
element-the antioxidant responsive element (ARE; 5′-(A/
G) TGACNNNGC(A/G) -3′) [5], and Nrf2, a member of
the Cap’n’ Collar family of transcription factors, which
mainly regulates transcriptional activation through the
ARE [6]. The Nrf2/ARE signal pathway has been consid-
ered to protect cells against carcinogenesis and attenuate
cancer development via neutralization of ROS or carcino-
gens [7,8]. Nrf2-deficient mice were more susceptible to
carcinogenesis, suggesting that Nrf2/ARE mediates the
phase II detoxifying enzymes and antioxidant proteins in
the inactivation of chemical carcinogens [9].Figure 1 Effects of digitoflavone on ARE–luciferase activity. (A) Chemi
molecular weight is 286.23. (B-C) Effects of digitoflavone on ARE–luciferase ac
concentrations of digitoflavone for 8 hours and 24 hours respectively, luci
(D-E) HEK-293 cells, HepG2 cells were treated with various concentrations
described in Materials and Methods. (F) Cell viability of digitoflavone in Ca
concentrations (1–20 μM) of digitoflavone for 24 hours, cell viability were
triplicate experiments. Significantly different (versus control group): *p<0.0Functional foods act as antioxidant nutrients and pro-
tect against many human chronic diseases by combating
reactive oxygen species (ROS) generation [10,11]. As diet
antioxidants, flavonoids, polyphenolic compounds occur-
ring naturally in the plant kingdom such as vegetables,
fruits and plant-derived beverages such as tea, cocoa, and
red wine, display a wide range of pharmacological proper-
ties, including anti-carcinogenesis and anti-inflammation
[12]. Flavonoids also exert a potent antioxidant activity,
acting as reactive oxygen species (ROS) scavengers, metal
ions chelators and free radical reaction terminators [13].
However, they can also act indirectly as antioxidants
stimulating phase II detoxifying and antioxidant defense
enzymes to preserve cellular integrity and tissue homeo-
stasis [14]. Digitoflavone (3, 0, 4, 5, 7-tetrahydroxyflavone,
Figure 1A), a flavone subclass of flavonoids, vegetables
and fruits such as celery, parsley, broccoli, onion leaves,
carrots, peppers, cabbages, apple skins, and chrysanthe-
mum flowers are digitoflavone rich [15-18]. Plants rich in
digitoflavone have been used as Chinese traditional medi-
cine for hypertension, inflammatory diseases, and cancer
[19]. Also, it has been known to have chemopreventive ef-
fects against malignant tumors in vivo [20,21]. Our recent
study has found digitoflavone induce G2 phase cell cycle
arrest, inhibit angiogenesis and down-regulate expressioncal structure of digitoflavone (3, 0, 4, 5, 7-tetrahydroxyflavone). Its
tivity in Caco-2 and HT-29 cells. Caco-2 cells were treated with various
ferase activity was assayed as described in Materials and Methods.
of digitoflavone for 8 hours and luciferase activity were assayed as
co-2, HT-29, HepG2 and HEK-293 cells. Cells were treated with various
determined using MTT assay. Values were expressed as mean ± SD of
5 and **p<0.01.
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digitoflavone due to its strong antioxidant and radical
scavenging properties [25]. However, as a diet compound,
digitoflavone’s antioxidant function on gastrointestinal
tract is not fully understood.
In the present work, we have investigated the action of
digitoflavone to protect Caco-2 cells, a human cell line
originating from gastrointestinal tract that retains many of
the morphological and enzymatic features typical of nor-
mal human enterocytes, against oxidative stress and fur-
ther in vivo study of its chemopreventive effect in AOM-
DSS induced CRC model. Our results demonstrate for the
first time that digitoflavone is able to attenuate oxidative
injury in colonic cells by up-regulate the expression of the
antioxidant defense enzymes via a mechanism that in-
volved p38 MAPKs activation and Nrf2 translocation and
further confirmed chemopreventive effect by free radical
scavenging and inhibition of inflammation.
Result
Digitoflavone induced high levels of ARE-driven luciferase
activities in Caco-2, HT-29, HepG2 and HEK-293 cells
A DNA fragment containing 8 copies of the ARE se-
quence (GTGACAAAGCACCC) were subcloned into the
pGL3 vector. After transient transfection with the expres-
sion plasmid, different concentrations of digitoflavone
were added to the cell culture and incubated for 8 hours
and 24 hours respectively. Parallel cell viability assays re-
vealed no obviously cytotoxic effects (>95% viability) for
the digitoflavone treatment when the concentration of
digitoflavone is lower than 10 μM in Caco-2, HepG2,
HEK-293 cells and 5 μM in HT-29 cells (Figure 1F).
10 μM digitoflavone induced the highest level of luciferase
activity after 8 hours exposure, about 5-fold increases of
control (Figure 1B). Another human epithelial colorectal
adenocarcinoma cell line HT-29 also showed that low
concentrations (5 μM) of digitoflavone can increase the
ARE-luciferase activity with no obviously cytotoxic effects
(Figure 1C). To evaluate the ARE-driven luciferase activity
of digitoflavone in other cell lines, HepG2 (Figure 1D) and
HEK-293 (Figure 1E) cell lines were transient transfected
with the pGL3-ARE-luciferase plasmid respectively and
tested with 1–20 μM digitoflavone for 8 hours. All tested
cell lines showed over 2-fold increases of the luciferase ac-
tivity at 1–10 μM concentrations of digitoflavone. These
result suggested that digitoflavone, at low concentrations
(<10 μM), is a potent activator of the Nrf2/ARE antioxi-
dant pathway.
Digitoflavone stimulated the expression of the
Nrf2-ARE-mediated antioxidant defense proteins in
Caco-2 cells
To verity whether activation of luciferase activity by digi-
toflavone in Caco-2 cells reflected the expression of theendogenous ARE-driven genes, the mRNA levels of GR,
TR, HO-1, γ-GCSc, γ-GCSm, NQO1, and MRP2 were
examined in the presence or absence of digitoflavone.
In Caco-2 cells treated with 10 μM digitoflavone for
8 hours, the mRNA levels of GR, TR, HO-1, γ-GCSc, γ-
GCSm, UGT1A1 and UGT1A10 increased 1.2-, 6.0-, 1.5,
1.7-, 1.8-, 1.5, 1.8-fold, respectively (Figure 2A). Simi-
larly, evaluation of the Nrf2-mediated antioxidant en-
zymes, such as γ-GCSc and TR by Western blotting
showed that exposure of Caco-2 cells to 1–15 μM digi-
toflavone strongly induced γ-GCSc, γ-GCSm and TR
protein expression in a dose and time-dependent man-
ner (Figure 2).
Digitoflavone induced Nrf2 protein expression and
nuclear translocation
Previous studies described that under normal conditions,
Keap1 sequestered Nrf2 in the cytoplasm and that trans-
location of Nrf2 into the nucleus is essential for the
transactivation of various targeted genes [26,27]. There-
fore, to further investigate effects of digitoflavone one
the Nrf2/ARE activation, we examined the protein ex-
pression and subcellur location of Nrf2 in Caco-2 cells
after digitoflavone treatment. As show in the Figure 2B,
Western blot analysis demonstrated a significant in-
crease of Nrf2 protein expression after digitoflavone
treatment in dose- and time-dependent manner. West-
ern blot analysis of the nuclear fraction (Figure 2C) and
Immunofluorescence analyses (Figure 2D) showed Nrf2
accumulation in the nucleus of Caco-2 cells after digito-
flavone treatment.
To confirm the requirement of Nrf2 in the digitoflavone-
induced antioxidant activities, we transfected the Caco-2
cells with Nrf2 target siRNA before digitoflavone treatment.
As show in Figure 2E, silencing Nrf2 expression signifi-
cantly inhibited the digitoflavone-induced γ-GCSc, γ-
GCSm and TR up-regulation, suggesting that digitoflavone
induced antioxidant activities in an Nrf2/ARE-dependent
manner.
We also investigated changes in GSH content in Caco-
2 cells after incubation in varying concentrations of digi-
toflavone for 8 h. Digitoflavone increased GSH content
and decreased the level of GSSG in a dose-dependent
manner, which resulted in a dose-dependent increase in
the ratio of GSH/GSSG (Figure 2F-H). This result is
consistent with increased levels of γ-GCSc and γ-GCSm
mRNAs, which encode the rate-limiting enzymes in
GSH synthesis, in Caco-2 cells.
Digitoflavone exhibited cytoprotective effects against
H2O2-induced oxidative stress in Caco-2 cells
Nrf2 is a key component in protection against carcino-
genesis and oxidative stress [26,28,29]. Previous reports
have suggested that oxidative stress plays an important
Figure 2 Effects of digitoflavone on mRNA and protein levels of Nrf2-mediated phase II enzymes-antioxidant proteins, Nrf2 expression
and nucleus accumulation in Caco-2 cells. (A) Effects of digitoflavone on mRNA levels of the selected ARE genes. Caco-2 cells were treated
with 10 μM digitoflavone for 8 hours and the mRNA levels of all selected genes were evaluated using RT-PCR. (B) Dose and time effect of digitoflavone.
Caco-2 cells were treated with various concentrations (0–15 μM) of digitoflavone for 8 hours (top) and 10 μM digitoflavone for 0–8 hours (bottom). Nrf2,
γ-GCSc, γ-GCSm and TR expression level were determined using Western blotting. (C) Time effect of Nrf2 nucleus accumulation. Caco-2 cells were
treated with 10 μM digitoflavone for 0–8 hours. Total form Nrf2 in nucleus (N) and cytoplasm (C) were determined using Western blotting.
(D) Immunofluorescence staining of Nrf2. Caco-2 cells were treated with 10 μM digitoflavone for 0–8 hours and then Nrf2 was labeled with
immunofluorescence staining. Cells were counter-stained with DAPI for visualization of the nuclei. The left panel shows the relative signal-intensity
profiles of Nrf2 and DAPI along the cross sections at the light yellow line. White scale bar indicates 25 μm. (E) Nrf2 silencing abrogates
digitoflavone-induced cytoprotective protein expression. After 48 h transfection, the cells were treated with 10 μM digitoflavone for 8 hours
and whole-cell lysates (TL) were then prepared. The protein levels of Nrf2, γ-GCSc, γ-GCSm and TR were analyzed. (F-H) Effects of digitoflavone
on cellular total GSH, GSSG and the ratio of GSH/GSSG. Caco-2 cells were treated with various concentrations of digitoflavone for 8 hours, and
the total GSH, GSSG and the GSH/GSSG ratio were analyzed according to the manufacturer’s instructions. The values represent the means ± SD
of triplicate experiments. Significantly different (versus control group): *p<0.05, **p<0.01.
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http://www.molecular-cancer.com/content/13/1/48role in tumor promotion [30,31]. H2O2 may induce self-
generation of free radicals known as the ROS-induced
ROS release at the mitochondrial level [32], which has
been widely used as a model of exogenous oxidative stress.
In this study, we validated if antioxidant activities induced
by digitoflavone can actually protect against H2O2-in-
duced damage in Caco-2 cells. The protective effects of
digitoflavone against the H2O2-induced cytotoxicity were
detected by MTT assay. As show in Figure 3A and B, pre-
treatment of digitoflavone for 4 h exhibited dose-dependent
protective effects in the H2O2-damage model and the
Nrf2 target siRNA transfection group (Figure 3C), while
the GSH synthesis inhibitor BSO partially abolished the
digitoflavone-induced protective effect (Figure 3D).Figure 3 Effects of digitoflavone on oxidative stress-induced cell inju
Caco-2 cells were pretreated with 10 μM digitoflavone for 4 hours then esp
viability was determined using MTT assay. (B) Dose-dependent anti-oxidati
digitoflavone for 4 hours then espoused to 500 μM H2O2 for an additional
partly abrogates digitoflavone-induced cytoprotective effect. After 48 h tran
and followed an oxidative stress of 500 μM H2O2 for 24 hours, Cell viability
partly abrogates digitoflavone-induced cytoprotective effect. Caco-2 cells w
with 10 μM digitoflavone for an additional 4 hours, anti-oxidative ability wa
(E) Flow cytometry analysis of the intracellular ROS. Caco-2 cells were treated
to 500 μM H2O2 for an additional 4 h. Intracellular ROS levels were measured
(G) Flow cytometry analysis of the apoptotic rate. Caco-2 cells were treated w
to 500 μM H2O2 for an additional 6 h. cells were stained with FITC-Annexin V-
the apoptotic rate. The values represent the means ± SD of triplicate experimIntracellular ROS levels affect cell viability and high
ROS levels can cause cellular damage. Using flow cytome-
try analysis, we examined the effects of digitoflavone on
intracellular ROS levels. As shown in Figure 3E and F,
H2O2 treatment led to a significant increase in ROS levels.
Statistical analysis showed that digitoflavone reduced the
H2O2-induced intracellular ROS level in a dose-dependent
manner. We further confirmed the anti-apoptotic effects
of digitoflavone through the quantitative analysis of FITC-
Annexin V/PI staining by flow cytometry. In the normal
control group, the percentage of apoptotic cells was 8.7%.
The percentage of apoptotic cells increased up to 33.9%
in the H2O2 model group (Figure 3G and H). The pro-
tective effects of digitoflavone against cell apoptosis wasry in Caco-2 cells. (A) The anti-oxidative ability of digitoflavone.
oused to various concentration of H2O2 for an additional 24 h. Cell
ve ability of digitoflavone. Caco-2 cells were pretreated with 1–15 μM
24 h. Cell viability was determined using MTT assay. (C) Nrf2 silencing
sfection, the cells were treated with 10 μM digitoflavone for 4 hours
was determined using MTT assay. (D) GSH synthetise inhibitor-BSO
ere pretreated with 10 μM BSO for 2 hours, then cells were treated
s tested with 500 μM H2O2 for an additional 24 h using MTT assay.
with various concentrations of digitoflavone for 4 hours before espoused
using DCF fluorescence. (F) Statistical analysis of the flow cytometry date.
ith various concentrations of digitoflavone for 4 hours before espoused
PI, flow cytometry measured the apoptotic rate. (H) Statistical analysis of
ents. Significantly different: *p<0.05, **p<0.01.
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and 21.2 ± 1.18% for 1 and 10 μM digitoflavone treat-
ment respectively).
Role of p38 MAPK in the digitoflavone-induced Nrf2-ARE
activation in Caco-2 cells
Under normal conditions, the interaction of Nrf2 with
the Kelch-like ECH-associated protein 1 (Keap1) traps
Nrf2 in the cytosol, leading to a rapid degradation of the
cytosolic Nrf2 by the 26S proteasome, via the Cullin3-
based E3-ligase ubiquitination complex [26]. A number
of studies have shown that several signaling pathways,
including PI3K [33,34], MAPK [35,36], and PKC [37,38],
are involved in the induction of Nrf2/ARE-driven gene
expression. To elucidate the signal transduction path-
ways leading to the activation of Nrf2 and the induction
of antioxidants expression in the digitoflavone-treated
cells, we examined the effects of digitoflavone on the ex-
pression of Keap1 and the phosphorylation of PKC, AKT,
ERK1/2, and p38 MAPK. Upon digitoflavone treatment,
time-dependent increases in the phosphorylation of AKT,
ERK1/2, and p38 MAPK were observed (Figure 4A). To
determine whether such activations of AKT, ERK1/2, and
p38 MAPK contribute to the digitoflavone-induced Nrf2
activation, several kinase inhibitors, including wortmannin
(for PI3K), PD98059 (for MEK1/2), and SB202190 (for
p-p38 MAPK), were employed. As show in Figure 4B-D,
inhibition of the phosphorylation of AKT and ERK1/2
did not decrease the digitoflavone-induced Nrf2 activation.Figure 4 Effects of signaling inhibitors on digitoflavone-induced Nrf2
digitoflavone-induced Nrf2 activation. Caco-2 cells were treated with 10 μM
upstream kinases were determined using Western blotting and appropriate
induced Nrf2 activation. Caco-2 cells were pretreated with various concent
for 2 hours respectively, then cells were treated with 10 μM digitoflavone f
using Western blotting. (C-D) Caco-2 cells were pretreated with 10 μM PD9
treated with 10 μM digitoflavone for an additional 4 hours, anti-oxidative a
assay. The values represent the means ± SD of triplicate experiments. SignifHowever, the p38 MAPK inhibitor SB202190 signifi-
cantly inhibited the digitoflavone-induced Nrf2 activa-
tion (Figure 5A) and nuclear accumulation (Figure 5B).
To determine whether such activation of p38 MAPK
contribute to the digitoflavone-mediated protections
against the cytotoxic effects of H2O2, the Caco-2 cells
were pre-incubated with SB202190 for 2 hours before
the 4 hours digitoflavone treatment, Cells were then
challenged with 500 μM H2O2 for additional 24 h for
MTT assay, 4 h for ROS detection, and 6 h for apoptosis
detection, respectively. As show in Figure 5C, SB202190
eliminated the protective effects of digitoflavone. SB20
2190 also reversed the digitoflavone antioxidant activity
(Figure 5D and E). Further, the anti-apoptosis ability of
digitoflavone was also abolished by SB202190 (Figure 5F
and G).
The chemopreventive effect of digitoflavone on tumor
progression in mice
We further explored chemopreventive effects of digitofla-
vone on tumor progression by administering it to mice
from week 2 to day 13, after the AOM and 3 cycles of
DSS treatments (Figure 6A). Compared with the AMO
group, digitoflavone treatment reduced the numbers and
size of macroscopical tumors remarkably and the shorted
colon length was resvered by digitoflavone when compared
with AOM group, also less loss of crypts was observed
in mice with digitoflavone treatment (Figure 6B-D).
Next, activation of Nrf2 and its downstream targetsand γ-GCSc expression in Caco-2 cells. (A) Possible mechanism of
digitoflavone for 0, 1, 2, 4, 8 hours, Keap1 expression level and Nrf2
specific antibodies. (B) Role of Erk1/2 and PI3K/AKT in digitoflavone-
ration of PD98059 (MEK1/2 inhibitor), wortmannin (for PI3K inhibitor)
or an additional 8 hours, Nrf2 and γ-GCSc expression were determined
8059 or 10 μM wortmannin for 2 hours respectively, then cells were
bility was tested with 500 μM H2O2 for an additional 24 h using MTT
icantly different: *p<0.05, **p<0.01.
Figure 5 Digitoflavone activates the Nrf2/ARE axis and induces cytoprotective effect via the p38 MAPK pathway. (A) Effects of p38
signaling inhibitoγ-SB202190 on digitoflavone-induced Nrf2 expression. Caco-2 cells were pretreated with various concentration of p38 signaling
inhibitors-SB202190 for 2 hours then treated with 10 μM digitoflavone for an additional 8 hours. Nrf2, γ-GCSc and TR protein expression was
determined using Western blot analysis. (B) Effects of p38 signaling inhibitor-SB202190 on digitoflavone-induced Nrf2 translocation. Caco-2 cells
were pretreated with 10 μM SB202190 for 2 hours then treated with 10 μM digitoflavone for 0, 4, 8 hours. Nrf2 in nucleus (N), cytoplasm (C) were
determined using Western blotting and appropriate specific antibodies. Lamin B and GAPDH were used as internal controls for nuclear and
cytoplasmic extracts, respectively. (C) Cell viability analysis. Caco-2 cells were preincubated with or without 10 μM SB202190 then treated with
various concentrations of digitoflavone for 4 hours before espoused to 500 μM H2O2 for an additional 24 hours. Cell viability was determined
using MTT assay. (D) Flow cytometry analysis of the intracellular ROS. Caco-2 cells were preincubated with or without 10 μM SB202190 then
treated with various concentrations of digitoflavone for 4 hours before espoused to 500 μM H2O2 for an additional 4 hours. Intracellular ROS levels
were measured using DCF fluorescence. (E) Statistical analysis of the flow cytometry date. (F) Flow cytometry analysis of the apoptotic rate. Caco-2 cells
were preincubated with or without 10 μM SB202190 then treated with various concentrations of digitoflavone for 4 hours before espoused to 500 μM
H2O2 for an additional 6 hours. cells were stained with FITC-Annexin V-PI, flow cytometry measured the apoptotic rate. (G) Statistical analysis of the
apoptotic rate. The values represent the means ± SD of triplicate experiments. Significantly different: *p<0.05, **p<0.01.
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digitoflavone against tumor progression is attributed to
activation of the Nrf2 pathway. Protein expression of Nrf2
and Nrf2 downstream targets TR, γ-GCSc and γ-GCSm
and mRNA expression of GR, TR, HO-1, γ-GCSc, γ-
GCSm, NQO-1, UGT1A1 and UGT1A10 were slightly
changed in AOM group, indicating induction of the Nrf2
pathway by colon oxidative stress. As expected, treatment
with digitoflavone markedly increased the protein levels of
Nrf2, TR, γ-GCSc, γ-GCSm and HO-1 and mRNA levels
of GR, TR, HO-1, γ-GCSc, γ-GCSm, NQO-1, UGT1A1
and UGT1A10 (Figure 6E and F). The mRNA Levels of
colonic inflammatory cytokines TNF-a, IL-1β and IL-6were increased in AOM group, and digitoflavone reduced
TNF-a, IL-1β and IL-6 mRNA Levels when compared
with AOM group (Figure 6G).
Discussion
The intestinal epithelium sits at the interface between an
organism and its luminal environment, and as such is
prone to oxidative damage induced by luminal oxidants.
The intestinal epithelial cells, as a barrier between an or-
ganism and its intestinal contents, are the first line of
defense against frequent exposure to xenobiotics contain-
ing chemical toxicants [39]. In the biological defense
process, intestinal epithelia express detoxification enzymes
Figure 6 The effects of digitoflavone on colon carcinogenesis. (A) Schematic overview of digitoflavone administration. Colons were removed
at week 13 after the mice were administered digitoflavone or a vehicle control between week 2 and 13. (B) The tumor numbers, sizes and colon
length were determined macroscopically. The bars represent the median of each group. Each symbol represents the tumor numbers and colon
length of each animal or the average size of the tumors of each animal. Significantly different: *p<0.05, **p<0.01. (C) Macroscopic evaluation of
the tumors. Colons were removed on week 13 from mice, treated with digitoflavone or with vehicle. Representative results from 6 independent
animals are shown here. Original magnification, ×6. (D) Colons were processed for hematoxylin and eosin staining and representative results from
6 independent animals are shown here. Original magnification, × 40. (E) Immunoblotting analysis with anti–Nrf2, TR, γ-GCSc, γ-GCSm and HO-1
antibodies was performed on cell lysates from colon tissues as described in Methods. Representative results from 3 independent experiments are
shown here (left panel), the intensity of bands from replicate immunoblots was quantified and plotted (right panel, bar graphs). Significantly
different (versus control group): *p<0.05, **p<0.01. (F-G) Quantitative RT-PCR analysis for GR, TR, HO-1, γ-GCSc, γ-GCSm, NQO-1, UGT1A1, UGT1A10,
TNF-a, IL-1βand IL-6 was performed on total RNAs extracted from the colons. All genes’ mRNA levels were normalized to the levels of GAPDH
mRNA. Significantly different (versus control group): *p<0.05, **p<0.01 and NS, not significant.
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and exclusion of the xenobiotics [40]. Oxidative stress is
associated with mucosal erosions and has a causative role
in a variety of gastrointestinal diseases such as Crohn’s
disease and ulcerative colitis [41,42]. In particular, dietary
pro-oxidants may alter the redox status of intestinal cells
and provoke inflammatory bowel disease and colon
cancer. Epidemiological studies have related a diet rich
in fruits and vegetables to the prevention of chronic de-
generative diseases linked to oxidative stresses [43].
The antioxidant and chemoprotective properties of food
flavonoids or polyphenolic extracts have been widely
reported in cultured cells [43], animal models [44], and
humans [45,46].
There is a substantial body of scientific literatures that
supports a positive role of flavonoids on health [13]. The
mechanisms by which the specific flavonoids exert these
benefits are under intense investigation. Digitoflavone is acommon dietary flavonoid that can be found in a large
number of plants and foods and it has been found to
possess anti-oxidant, anti-inflammatory/anti-allergic, anti-
tumorigenic, and radical action [47,48]. In this study, we
demonstrated that the flavones digitoflavone inhibited
H2O2-induced oxidative stress and that this suppression
was likely associated with the up-regulation of γ-GCSc
and γ-GCSm expression through the p38/Nrf2 pathway.
The human colon carcinoma cell line Caco-2 and its
derivatives have been widely used in studies on molecu-
lar effects of and inter-actions with xenobiotics. The cell
line undergoes differentiation during culture, which re-
sults in an ileum cell like model system, as well as a
model system for cells of the small intestine [49,50].
Using the Caco-2 cells, we explored the potential mo-
lecular mechanisms underlying the chemopreventive
and antioxidant effects of digitoflavone, focusing on ARE
activation. We found that digitoflavone acts as an ARE
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HT-29 (Figure 1C), but also in many other types of cells
(Figure 1D-E). Numerous studies have suggested that
ARE sequences are involved in regulating the expression
of a wide array of antioxidant and detoxifying genes [51],
and Nrf2 serves as a master regulator of the ARE-driven
cellular defense system against oxidative stresses.
Under normal conditions, Nrf2 is sequestered by
Keap1, a substrate adaptor, which helps Cullin 3 ubiqui-
tinate Nrf2 in the cytoplasm, and ARE activation signals
(i.e., protein kinase pathway and redox-active compo-
nents) disrupt the Nrf2/Keap1 complex, leading to
phosphorylation and nuclear translocation of Nrf2. Nrf2
then heterodimerizes with small Maf and binds to ARE,
eventually resulting in transcriptional activation of the
ARE-mediated metabolizing/detoxifying and antioxi-
dant genes [9]. We report in this study that digitofla-
vone strongly induced Nrf2 protein expression and
nucleus accumulation (Figure 2B-D). The rapid accu-
mulation of Nrf2 in the nucleus in response to digitofla-
vone is consistent with reported results with other Nrf2
activators, such as PEITC [36] and celecoxib [34], and
with the Nrf2 degradation inhibitors such as eckol [52].
The Nrf2/ARE pathway activates approximately 100
cytoprotective genes [14]. In this study, digitoflavone ele-
vated the mRNA and protein levels of several ARE-
mediated antioxidant/detoxifying genes in Caco-2 cells
(Figure 2A and B). Knockdown of Nrf2 by Nrf2-targeted
siRNA markedly suppressed the digitoflavone-induced γ-
GCSc, γ-GCSm expression (Figure 2D), suggesting that
digitoflavone up-regulates Nrf2-dependent activation of
the ARE-regulated genes. Nrf2 controls the expression
of γ-GCSc and γ-GCSm, which together catalyze the
rate-limiting step in GSH biosynthesis [53]. Involvement
of GSH in the digitoflavone-induced cytoprotection
against oxidative injury could not be excluded, because
increasing GSH levels would be expected to reduce ROS
levels and antagonize the ROS-induced cell death [53].
In this study, treatment of cells with digitoflavone resulted
in decreased H2O2-induced oxidative stress (Figure 3E
and F), and cell death (Figure 3G and H).
Activation of Nrf2 involves regulation of protein kinases,
which may induce Nrf2 phosphorylation and nuclear
translocation [54-57]. The MAPK cascade, PI3K/AKT,
and PKC signaling pathways have been reported to influ-
ence the Nrf2/ARE pathway [57]. For example, phosphor-
ylation of Nrf2 by PKC promotes its release from Keap1
[6] and inhibition of PI3K attenuates the nuclear trans-
location of Nrf2 and transcription of ARE-mediated genes
[58]. To identify which signal cascade controlled activa-
tion of Nrf2 by digitoflavone, we examined the effects of
PI3K inhibitor, ERK1/2 inhibitor, and p38 MAPK inhibitor
on the digitoflavone-induced Nrf2 up-regulation. Our re-
sults demonstrated that PI3K/AKT and ERK1/2 are notinvolved in the digitoflavone-induced activation of the
Nrf2/ARE pathway because their inhibitor had no effect
on enhanced digitoflavone-induced Nrf2 up-regulation
(Figure 4B-D). On the contrary, inhibition of p38 MAPK
by SB202190 leads to decrease of the digitoflavone-
induced Nrf2 up-regulation, indicating that the digitoflavone-
induced Nrf2 activation is dependent on the activation
of p38 MAPKs. Inhibition of p38 also abrogated the
digitoflavone-induced translocation of Nrf2 to nucleus
and the antioxidant defense effect, demonstrating that
the crucial role of p38 in the Nrf2-dependent activation
of ARE and suggesting that Nrf2 is a downstream effector
of p38 kinase in response to digitoflavone treatment.
In vivo experiment we study the chemopreventive role
of digitoflavone in AOM-DSS induced colorectal cancer
model. Digitoflavone was post-treated after the initiation
of stage of colorectal cancer. Compared with AOM
group, digitoflavone group shown lower cancer incidents
(50% compare with AMO group 100%), reduced num-
bers and size of macroscopical tumors and recovered
colon length (Figure 6B-C). General histological observa-
tion found that digitoflavone retained a better colonic his-
toarchitecture with less loss of crypts (Figure 6D). Further
protein and mRNA level Analysis indicated the chemopre-
ventive role of digitoflavone may through the activation of
Nrf2 and inhibition of inflammation (Figure 6E-G).
In summary, our study demonstrates for the first time
that digitoflavone improved the intestinal antioxidant
potential through the induction of the main detoxifica-
tion enzyme γ-GCSc and γ-GCSm by a mechanism in
which activation of p38 MAPK plays an essential role
(Figure 7). In addition, digitoflavone was identified as a
potent inducer of Nrf2 expression and translocation pro-
viding a support for the involvement of this transcription
factor in the induction of γ-GCSc and γ-GCSm. The re-
sults of the present study add further evidence of the
molecular mechanisms that allow digitoflavone to exert
protective effects and reaffirm its potential role as a che-
mopreventive agent in colorectal carcinogenesis.
Material and method
Material
AOM, DSS (MW 36,000–50,000), digitoflavone, SB202190,
DCFH-DA [2′, 7′-Dichlorofluorescin diacetate], Trypsin,
MTT [3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazo-
liμM bromide], BSO [L-Buthionine-sulfoximine ], DNase-free
RNase and SB202190 were obtained from Sigma-aldrich,
USA. Digitoflavone was dissolved in dimethyl sulfoxide
(DMSO) and was used in all experiments. Maxima® SYBR
Green/ROX qPCR Master Mix (2×) and Maxima® First
Strand cDNA Synthesis Kit were purchased from Fermen-
tas life science (Fermentas, MBI). PD98059, Wortmannin,
Lysis buffer was purchased from Beyotime, China. Primary
antibodies (Nrf2 for mouse, γ-GCSc, γ-GCSm, TR, HO-1,
Figure 7 A proposed pathway for digitoflavone-induced Nrf2/ARE-mediated cytoprotective proteins via activation of p38 MAPK signaling.
Up-regulation of γ-GCSc, γ-GCSm explains the cytoprotective effects against oxidative stress in Caco-2 cells.
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Biotechnology, CA, USA. Rabbit anti-Nrf2 (for human)
was purchased from Abcam, USA. Primary antibodies
(p-PKC, ERK1/2, p-ERK1/2, p-p38, p38, AKT and p-
AKT) were purchased from Cell Signaling Technology,
MA, USA. Goat anti-rabbit IgG and goat anti-mouse
IgG antibodies were purchased from LI-COR, Lincoln,
NE, USA. Rabbit anti-Goat IgG was obtained from
KPL, Gaithersbhrg, MD, USA. Monoclonal mouse anti-
glyceraldehyde-3-phosphate dehydrogease (GAPDH)
was obtained from KangChen, China.
Cell lines and cell culture
Human epithelial colorectal adenocarcinoma cell line
Caco-2, Human colon adenocarcinoma grade II cell line
HT-29, human liver carcinoma cell line HepG2 ,Human
Embryonic Kidney 293 cell HEK-293 were purchased from
Cell Bank of Shanghai Institute of Biochemistry and Cell
Biology. Cells were cultured in DMEM-medium (for
HepG2, HEK-293 cells), MEM-medium (for Caco-2 cells),
McCOY’s 5A(for HT-29) supplemented with 10% fetal bo-
vine serum (FBS), 100 U/ml penicillin and 100 μg/ml
streptomycin (all available from Invitrogen, Grand Island,
NY, USA). All cultures were maintained in a humidified
environment with 5% CO2 at 37°C.
Transient transfection and analysis of luciferase reporter
gene activity
We used the luciferase reporter assay to investigate the
Nrf2-mediated transcriptional activity of Nrf2. Firstly, 8
copies of antioxidant-responsive element (ARE)–luciferasereporter plasmids were generated using the pGL3 pro-
moter vector (Promega UK). After the plasmids were gen-
erated, the DNA sequence of the inserts was verified. The
Dual-Luciferase Reporter Assay System (Promega, UK)
was used to determine reporter gene activity in transiently
transfected cells. Transient transfection was performed in
96-well plates at a cell density of 50% ~ 70% confluence
per well. Then the 8 × ARE pGL3 plasmid were co-
transfected with the pRL-TK plasmid(transfection ratio of
8 × ARE pGL3:pRL-TK is 10:1), encoding Renilla lucifer-
ase as an internal control for transfection efficiency for
24 h using Lipofectamine 2000 (Invitrogen, Carlsbad, CA,
USA) according to the manufacturer’s instructions. After
transfection, cells were treated with test samples for indi-
cated time, and then cell lysates were prepared for assess-
ment of luciferase activity. Fire fly and Renilla luciferase
activities were measured using a luminometer (Centro
XS3 LB960, Berthold, Germany) according to the manu-
facturer’s instructions. Relative fire fly luciferase activity
was normalized to Renilla luciferase activity and activity
was expressed as fold induction after treatment with com-
pounds compared with vehicle control (DMSO).
Cell viability assay
Cell viability was determined using the MTT assay.
Briefly, cells in logarithmic phase were seeded at the
density of 70 ~ 80% confluence per well in 96-well plates
at 37°C with 5% CO2 for overnight incubation and
treated with appropriate concentrations of test samples
for the indicated times. After treatment, 10 μl of 5 mg/ml
MTT was added and the cells were incubated for 4 h at
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was added to each well. The mixture was shaken on a
mini shaker at room temperature for 10 min and the spec-
trophotometric absorbance was measured by Multiskan
Spectrum Microplate Reader (Thermo, USA) at 570 nm
and 630 nm (absorbance 570 nm, reference 630 nm).
Triplicate experiments were performed in a parallel manner
for each concentration point and the results were presented
as mean ± SD. The net A570nm-A630nm was taken as the
index of cell viability. The net absorbance from the wells of
cells cultured with DMSO was taken as the 100% viability
value. The percent viability of the treated cells was calcu-
lated by the formula: % viability = (A570nm-A630nm) treated/
(A570nm-A630nm) control × 100%.
SDS –PAGE and Western blot analysis
Caco-2 cells were cultured in MEM and then treated
with test samples for indicated time. Proteins were iso-
lated by lysis buffer (Beyotime, China) and measured
using the Nanodrop 1000 Spectrophotometer (Thermo,
USA). Protein samples were separated on 10% SDS-
polyacrylamide gels (SDS-PAGE) and transferred onto
the PVDF membranes (Millipore, USA). After blocked
with 1% BSA in TBST for 2 h, membranes were incu-
bated with primary antibodies overnight at 4°C. Blots
were washed and incubated with secondary antibodies
for 1 h at room temperature. Membranes were again
washed three times with TBST and were scanned with
an Odyssey infrared fluorescent scanner (LI-COR) and
analyzed with Odyssey software version 3.
Determination of cellular reduced glutathione (GSH)
content
Caco-2 cells were treated with various concentrations of
digitoflavone (1–15 μM) or vehicle control (DMSO). After
8 h incubation, the cellular GSH and GSSG were quanti-
fied using GSH/GSSG-Glo Assay kit (Promega) according
to the manufacturer’s protocol. GSH and GSSG levels
were normalized to protein concentrations and the GSH/
GSSG ratio was calculated.
Immunofluorescence staining
Cells in logarithmic phase were seeded in logarithmic
phase were seeded at the density of 70 ~ 80% confluence
per well into 24-well chamber slides. After treatment
with test samples for the indicated times, cells were fixed
with cold 4% (w/v) paraformaldehyde for 20 min, rehy-
drated in PBS for 15 min, and permeabilized in 0.1% (w/v)
TritonX-100 at room temperature for 10 min. After be-
ing washed with PBS, the cells were blocked unspecific
fluorescence with 3%BSA for 1 hour and then incubated
with primary antibody at 4°C overnight followed by Texas
Red-conjugated secondary antibody for 1 h at roomtemperature. The images of Nrf2 with Texas Red staining
were captured using a fluorescence microscope.
Preparation of nuclear extract proteins
Nuclear extract protein was prepared according manufac-
tory’s instruction (Thermo, USA). Briefly, after treatment
with digitoflavone for indicated times, Caco-2 cells were
harvested, washed with PBS, centrifuged, and resuspended
in ice-cold buffer CERI. After 10 min of incubation on ice,
cells were added with ice-cold CERII and centrifuged
again, the supernatant (cytoplasmic extract) was immedi-
ately transferred to a clean pre-chilled tube. The insoluble
(pellet) fraction was resuspended with NER, and vortex
for 15 seconds every 10 min for a total 40 min. The tube
was centrifuged and the supernatant (nuclear extract) was
immediately transferred to a clean pre-chilled tube. The
cytoplasmic and nuclear extract protein was stored at −80°C
until use. For Western blot analysis, LaminB and GAPDH
were used as internal controls for nuclear and cytoplasmic
extracts, respectively.
Real-time reverse transcription –polymerase chain
reaction (RT-PCR)
Caco-2 cells were treated with different concentrations
of digitoflavone for indicated times, then treated cells were
washed with PBS, total RNA was extracted from the
treated cells using trizol reagent (Invitrogen, Carlsbad,
CA) and then RNA was converted to cDNA by reverse
transcriptase (Thermo, USA) according to the manufac-
turer’s instruction. Primers used for the reactions were
purchased from Genscript and the sequences were listed
in Table 1. Real-time qPCR analysis for mRNA expression
was performed using SYBR Green probes and an ABI
7500. ALL genes’ mRNA expression was normalized
against GAPDH expression.
Measurement of ROS
The production of cellular ROS, mainly H2O2, was de-
tected using the DCFH-DA fluorescence assay. Briefly,
cells were seeded in 24-well plates at the density of 70 ~
80% confluence per well for overnight incubation. After
treatment with appropriate concentrations of test samples,
cells were harvested, placed into 1.5 mL round-bottom
polystyrene tubes, and washed with PBS twice. Subse-
quently, the cells were centrifuged for 5 min at 400 × g at
room temperature, and the supernate was discarded. The
cells were resuspended in 500 μL ROS detection solution,
stained in the dark at 37°C for 30 min, and analyzed by
FACScan laser flow cytometer (Guava easycyteHT,
Millipore, CA).
Flow cytometric detection of apoptosis
Caco-2 cells in logarithmic phase at were treated with test
samples for indicated time. Then they were harvested,
Table 1 Primers used for real-time RT-PCR
Primer Sequences
hNrf2 Forward primer,5′- CATCCAGTCAGAAACCAGTGG
Reverse primer ,5′- GCAGTCATCAAAGTACAAAGCAT
hKeap1 Forward primer, 5′-CCTTCAGCTACACCCTGGAG
Reverse primer, 5′-CATGACCTTGGGGTGGATAC
hGR Forward primer, 5′-CACGGA GGAGCTGGAGAAC
Reverse primer, 5′- CGACAAAGTCTTTTTAACCTCCTT
hTR Forward primer, 5′-CAGACG GGGAGGCTTTTC
Reverse primer, 5′- CCGAGAGCGTTCCTTTCA
hHO-1 Forward primer, 5′- TCCTGGCTCAGCCTCAAATG;
Reverse primer, 5′- CGTTAAACACCTCCCTCCCC
hr-GCSc Forward primer, 5′-CTGTTGCAGGAAGGCATTGAT
Reverse primer, 5′- TTCAAACAGTGTCAGTGGGTCTCT
hr-GCSm Forward primer, 5′- GGCACAGGTAAAACCAAATAGTAAC
Reverse primer, 5′- CAAATTGTTTAGCAAATGCAGTCA
hNQO1 Forward primer, 5′- GGGATCCACGGGGACATGAATG
Reverse primer, 5′- ATTTGAATTCGGGCGTCTGCTG
hUGT1A1 Forward primer, 5′-TAAGTGGCTACCCCAAAACG
Reverse primer, 5′- TCCAGCTCCCTTAGTCTCCA
hUGT1A10 Forward primer, 5′- CGTGTTCTGGGTGGAGTTTG
Reverse primer, 5′- TTTTCCCCAAGCATTTCCGG
hGAPDH Forward primer, 5′- TGCACCACCAACTGCTTAGC
Reverse primer, 5′- GGCATGGACTGTGGTCATGAG
mGR Forward primer, 5′- AGTGCACTCGGAATTCATGC
Reverse primer, 5′- CAATCAGGATGTGTGGAGCG
mTR Forward primer, 5′- ATCCACAAACAGCGAGGAGA
Reverse primer, 5′- TTGGTCTGCTCTTCATCCGT
mHO-1 Forward primer, 5′- GCCACCAAGGAGGTACACAT
Reverse primer, 5′- GCTTGTTGCGCTCTATCTCC
mr-GCSc Forward primer, 5′- GGCCACTATCTGCCCAATTG
Reverse primer, 5′- TGTTCTTCAGAGGCTCCAGG
mr-GCSm Forward primer, 5′- GGAGGGGCTCTTAACTCCAG
Reverse primer, 5′- CTCAACACAGTGCCGAACAA
mNQO1 Forward primer, 5′- ACAGGTGAGCTGAAGGACTC
Reverse primer, 5′- GTTGTCGTACATGGCAGCAT
mUGT1A1 Forward primer, 5′- GGAGGCTGTTAGTGTTCCCT
Reverse primer, 5′- CCGTCCAAGTTCCACCAAAG
mUGT1A10 Forward primer, 5′- GACTCGGGCATTCATCACAC
Reverse primer, 5′- GCGCATGATGTTCTCCTTGT
mTNF-a Forward primer, 5′- GACCCCTTTACTCTGACCCC
Reverse primer, 5′- AGGCTCCAGTGAATTCGGAA
mIL-1b Forward primer, 5′- ACTCATTGTGGCTGTGGAGA
Reverse primer, 5′- TTGTTCATCTCGGAGCCTGT
mIL-6 Forward primer, 5′- CTGCAAGAGACTTCCATCCAGTT
Reverse primer, 5′- GAAGTAGGGAAGGCCGTGG
Table 1 Primers used for real-time RT-PCR (Continued)
mGAPDH Forward primer, 5′- CTCCCACTCTTCCACCTTCG
Reverse primer, 5′- CCACCACCCTGTTGCTGTAG
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determined with an FITC Annexin V Apoptosis Detection
Kit (BD Biosciences, USA) according to the manufac-
turer’s protocol. Briefly, the cells were washed and subse-
quently incubated for 15 min at room temperature in the
dark in 100 ul of 1 × binding buffer containing 5ul of
Annexin V-FITC and 5 ul of PI. Afterward, apoptosis was
analyzed by FACScan laser flow cytometer (Guava easycy-
teHT, Millipore, CA).RNA interference study
Nrf2-specific short interfering RNA (siRNA) and scramble
control siRNA were obtained from RIBOBIO (GuangZhou,
China). Transfection was performed using LipofectAMINE
2000, according to the manufacturer’s protocol, with
Nrf2-specific siRNA SMARTpool L-003755-00-0050; hu-
man NFE2L2 (NCBI Accession No. NM006164); target
sequences including TCCCGTTTGTAGATGACAA, GA
GAAAGAATTGCCTGTAA and GCAACAGGACATT-
GAGCAA. Briefly, cells were transfected with 10 nmol/L
siRNAs directed against Nrf2 and non-targeting scramble
control siRNA for 48 h, followed by treatment with the
test samples for the indicated times. The cells were har-
vested and the protein status, MTT test and flow cytome-
try analysis.Animal experiments
All animal experiments were conducted in accordance
with the NIH Guidelines for the Care and Use of Labora-
tory Animals. Pathogen-free 8- to 12-week old C57BL/6
male mice were housed in a temperature-controlled room
(22°C) with a controlled 12-h light/dark cycle. The mice
were given free access to diet and water during the course
of experiments. They were allowed to adapt to the Experi-
mental Animal Laboratory for 1 week before beginning
the experiment. Mice were injected intraperitoneally with
10 mg/kg body weight of AOM dissolved in physiological
saline. One week later, 2% DSS was given in the drinking
water over 7 days, followed by 14 days of regular water.
This cycle was repeated a total of 3 times. Body weight
was measured every week, and the animals were sacrificed
at week 13 for macroscopical inspection, histological ana-
lysis, and total RNA and protein extraction. In digitofla-
vone group, digitoflavone at 50 mg/kg dose suspended in
0.5% carboxymethyl cellulose (CMC) was given as gavage
to mice and mice of control group and AOM group were
given 0.2 mL 0.5% CMC solution every day from week 2
to week 13 (Figure 6A).
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Results are expressed as mean ± SD. Statistical tests were
performed using SPSS 15.0. Unpaired Student t tests
were used to compare the means of two groups. For
multiple comparisons between groups, a one-way ANOVA
was performed to detect statistical differences. Differences
within the ANOVA were determined using a Tukey’s post-
hoc test. P value of less than 0.05 was considered to be
statistically significant.
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